5-Bromo-2-chloro-4’-ethoxydiphenylmethane (CAS 461432-23-5)

Chemox Pharma is a leading global supplier and manufacturer of 5-Bromo-2-chloro-4’-ethoxydiphenylmethane (CAS No.: 461432-23-5), a crucial intermediate in the synthesis of Dapagliflozin, an anti-diabetic drug from the SGLT2 inhibitor class. Chemox Pharma, an ISO 9001:2015 certified company based in India, provides high-quality APIs and intermediates for research, development, and large-scale commercial production.

With strong emphasis on quality assurance, transparency, and strict regulatory compliance, Chemox Pharma ensures that every intermediate is delivered with consistency, reliability, and superior purity. The company meets global regulatory requirements (DCGI, WHO-GMP, FDA) and supports its products with full documentation.

Contact us if you are looking for a trusted supplier of 5-Bromo-2-chloro-4’-ethoxydiphenylmethane (CAS No.: 461432-23-5) to ensure smooth sourcing of intermediates, competitive pricing, and regulatory excellence. Chemox Pharma’s well-equipped R&D Centre is focused on process development, quality improvement, and cost optimization to provide sustainable solutions to global pharmaceutical industries.